Evidence map›Paper›PMID 34898027›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.

Ruth Rodríguez-Barrueco, Jessica Latorre, Laura Devis-Jáuregui, Aina Lluch, Nuria Bonifaci, Francisco J Llobet, Mireia Olivan, Laura Coll-Iglesias, Katja Gassner, Meredith L Davis and 13 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. International journal of molecular sciences · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 4 countries.

Ruth Rodríguez-BarruecoMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Jessica LatorreDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
Laura Devis-JáureguiMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Aina LluchMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.ORCID 0000-0003-4216-4436
Nuria BonifaciMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.ORCID 0000-0002-8193-6825
Francisco J LlobetMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Mireia OlivanMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.ORCID 0000-0002-8464-0827
Laura Coll-IglesiasMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Katja GassnerMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.ORCID 0000-0001-8533-6475
Meredith L DavisMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.ORCID 0000-0002-0589-8222
José M Moreno-NavarreteDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
Anna Castells-NobauDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
Laura Plata-PeñaMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Miki Dalmau-PastorAnatomy Unit, Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), L'Hospitalet de Llobregat, 08907, Spain.
Marcus HöringInstitute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, Regensburg, 93053, Germany.ORCID 0000-0002-3651-392X
Gerhard LiebischInstitute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, Regensburg, 93053, Germany.ORCID 0000-0003-4886-0811
Vesa M OlkkonenMinerva Foundation Institute for Medical Research (Biomedicum 2U), and Department of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland.
Maria Arnoriaga-RodríguezDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
Wifredo RicartDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
José M Fernández-RealDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
José M SilvaDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Francisco J OrtegaDepartment of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.ORCID 0000-0003-2111-769X
David Llobet-NavasMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Instituto de Salud Carlos III · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversity Hospital Regensburg · DEAmerican Orthopaedic Foot and Ankle Society · USDuke University · USIcahn School of Medicine at Mount Sinai · USInstitut d'Investigació Biomèdica de Girona · ESUniversity of Helsinki · FI

Funding

Instituto de Salud Carlos III CP17/00063Instituto de Salud Carlos III CP19/00109Instituto de Salud Carlos III MS17/00063Instituto de Salud Carlos III MS19/00109Instituto de Salud Carlos III PI18/00550Marató de TV3 Foundation 201623-30-31Ministerio de Ciencia e Innovación RTI2018-095611-A-I00Ministerio de Ciencia e Innovación RyC-2016-19671
6 · The paper itself

Abstract

The H19X-encoded miR-424(322)/503 cluster regulates multiple cellular functions. Here, it is reported for the first time that it is also a critical linchpin of fat mass expansion. Deletion of this miRNA cluster in mice results in obesity, while increasing the pool of early adipocyte progenitors and hypertrophied adipocytes. Complementary loss and gain of function experiments and RNA sequencing demonstrate that miR-424(322)/503 regulates a conserved genetic program involved in the differentiation and commitment of white adipocytes. Mechanistically, it is demonstrated that miR-424(322)/503 targets γ-Synuclein (SNCG), a factor that mediates this program rearrangement by controlling metabolic functions in fat cells, allowing adipocyte differentiation and adipose tissue enlargement. Accordingly, diminished miR-424(322) in mice and obese humans co-segregate with increased SNCG in fat and peripheral blood as mutually exclusive features of obesity, being normalized upon weight loss. The data unveil a previously unknown regulatory mechanism of fat mass expansion tightly controlled by the miR-424(322)/503 through SNCG.

Indexed as

Cell DifferentiationAdipogenesisAdipose TissueAnimalsFemalegamma-SynucleinHumansMaleMiceMice, Inbred BALB CMice, Inbred C57BLMicroRNAsNeoplasm Proteinsgamma-SynucleinMicroRNAsNeoplasm ProteinsSNCG protein, humanadipocytesadipose tissuemiR-424(322)/503obesityγ-Synuclein

Identifiers

PMID34898027
PMCPMC8811811
OpenAlexW4200340912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.